Li Xia, Zhang Ying, Shen Xin, Shen Guomiao, Gui Xiaohong, Sun Bin, Mei Jian, Deriemer Kathryn, Small Peter M, Gao Qian
Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Shanghai, 200032, China.
J Infect Dis. 2007 Mar 15;195(6):864-9. doi: 10.1086/511985. Epub 2007 Feb 1.
We sought to determine whether patients who had therapy failure with increasingly drug-resistant strains of tuberculosis had primary or acquired drug resistance, by genotyping the initial and subsequent drug-resistant clinical isolates of Mycobacterium tuberculosis collected from patients by the Shanghai Centers for Disease Control and Prevention over the course of a 5-year period. The vast majority of patients (27/32) had primary drug resistance, indicating transmission of a drug-resistant strain of M. tuberculosis. Only 16% (5/32) had acquired drug resistance because of a poor treatment regimen or nonadherence to an adequate regimen. Our findings highlight the urgency of increasing efforts to interrupt the transmission of drug-resistant tuberculosis in communities and facilities in Shanghai, China.
我们试图通过对上海市疾病预防控制中心在5年期间从患者收集的结核分枝杆菌初始及后续耐药临床分离株进行基因分型,来确定那些对耐药性不断增强的结核菌株治疗失败的患者是原发性耐药还是获得性耐药。绝大多数患者(27/32)存在原发性耐药,这表明耐药结核分枝杆菌菌株发生了传播。只有16%(5/32)的患者因治疗方案不佳或未坚持适当方案而产生了获得性耐药。我们的研究结果凸显了在中国上海的社区和医疗机构加大力度阻断耐药结核病传播的紧迫性。